Wait and see in rectal cancer after neoadjuvant chemoradiotherapy
10.3760/cma.j.issn.1673-422X.2011.08.020
- VernacularTitle:直肠癌新辅助放化疗后的非手术治疗
- Author:
Haiqin ZHANG
;
Renben WANG
- Publication Type:Journal Article
- Keywords:
Rectal neoplasms;
Drug therapy;
Radiotherapy;
Wait and see
- From:
Journal of International Oncology
2011;38(8):620-623
- CountryChina
- Language:Chinese
-
Abstract:
Neoadjuvant chemoradiotherapy has been used as a standard treatment for patients with locally advanced (T2 and T3 ) rectal carcinoma. Some patients who receive neoadjuvant chemoradiotherapy obtain pathological complete remission, namely, the absence of any tumor cells in the surgical specimens. The patients who obtain pathological complete remission get a better survival rate after canceling operation. Researches are still needed to investigate whether it is safe for patients in order to avoid risk and adverse reaction.
